Elazzouzi Amy bought AURA
February 3, 2025 · Form 4 insider transaction
Elazzouzi Amy bought 45,240 shares of Aura Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
45,240
Price
$0.00
Total value
N/A
InsiderElazzouzi Amy
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 3, 2025
Filing dateFebruary 4, 2025
Shares owned after83,682
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on February 15, 2026, subject to the Reporting Person's continued service as of each such vesting date.